Induction of apoptosis by the new anticancer drug XK469 in human ovarian cancer cell lines
- 27 June 2002
- journal article
- Published by Springer Nature in Oncogene
- Vol. 21 (29) , 4530-4538
- https://doi.org/10.1038/sj.onc.1205545
Abstract
Oncogene is one of the world’s leading cancer journals. It is published weekly and covers all aspects of the structure and function of Oncogenes. Oncogene also publishes 8 Reviews issues a year, on a broad range of topics.Keywords
This publication has 32 references indexed in Scilit:
- Caspase 9 is required for p53-dependent apoptosis and chemosensitivity in a human ovarian cancer cell lineOncogene, 2002
- Cytotoxic Mechanism of XK469: Resistance of Topoisomerase IIβ Knockout Cells and Inhibition of Topoisomerase IBiochemical and Biophysical Research Communications, 2001
- Overexpression of Bcl2 Blocks TNF-Related Apoptosis-Inducing Ligand (TRAIL)-Induced Apoptosis in Human Lung Cancer CellsBiochemical and Biophysical Research Communications, 2001
- Mitochondrion as a Novel Target of Anticancer ChemotherapyJNCI Journal of the National Cancer Institute, 2000
- Induction of the TRAIL receptor KILLER/DR5 in p53-dependent apoptosis but not growth arrestOncogene, 1999
- TrueLeukemia, 1999
- The Bcl-2 Protein Family: Arbiters of Cell SurvivalScience, 1998
- Proteases to die forGenes & Development, 1998
- Prevention of Apoptosis by Bcl-2: Release of Cytochrome c from Mitochondria BlockedScience, 1997
- The Release of Cytochrome c from Mitochondria: A Primary Site for Bcl-2 Regulation of ApoptosisScience, 1997